GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Remedent Inc (OTCPK:REMI) » Definitions » Inventory-to-Revenue

Remedent (Remedent) Inventory-to-Revenue : 0.33 (As of Dec. 2020)


View and export this data going back to 2000. Start your Free Trial

What is Remedent Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Remedent's Average Total Inventories for the quarter that ended in Dec. 2020 was $0.11 Mil. Remedent's Revenue for the three months ended in Dec. 2020 was $0.34 Mil. Remedent's Inventory-to-Revenue for the quarter that ended in Dec. 2020 was 0.33.

Remedent's Inventory-to-Revenue for the quarter that ended in Dec. 2020 declined from Sep. 2020 (0.33) to Sep. 2020 (0.33)

A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Remedent's Days Inventory for the three months ended in Dec. 2020 was 78.77.

Inventory Turnover measures how fast the company turns over its inventory within a year. Remedent's Inventory Turnover for the quarter that ended in Dec. 2020 was 1.16.


Remedent Inventory-to-Revenue Historical Data

The historical data trend for Remedent's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remedent Inventory-to-Revenue Chart

Remedent Annual Data
Trend Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20
Inventory-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.11 0.04 0.07 0.10

Remedent Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 0.42 0.44 0.33 0.33

Competitive Comparison of Remedent's Inventory-to-Revenue

For the Medical Instruments & Supplies subindustry, Remedent's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Remedent's Inventory-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Remedent's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Remedent's Inventory-to-Revenue falls into.



Remedent Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Remedent's Inventory-to-Revenue for the fiscal year that ended in Mar. 2020 is calculated as

Inventory-to-Revenue (A: Mar. 2020 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Mar. 2019 ) + Total Inventories (A: Mar. 2020 )) / count ) / Revenue (A: Mar. 2020 )
=( (0.111 + 0.091) / 2 ) / 1.064
=0.101 / 1.064
=0.09

Remedent's Inventory-to-Revenue for the quarter that ended in Dec. 2020 is calculated as

Inventory-to-Revenue (Q: Dec. 2020 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Sep. 2020 ) + Total Inventories (Q: Dec. 2020 )) / count ) / Revenue (Q: Dec. 2020 )
=( (0.113 + 0.108) / 2 ) / 0.337
=0.1105 / 0.337
=0.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Remedent  (OTCPK:REMI) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Remedent's Days Inventory for the three months ended in Dec. 2020 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2020 )/Cost of Goods Sold (Q: Dec. 2020 )*Days in Period
=0.1105/0.128*365 / 4
=78.77

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Remedent's Inventory Turnover for the quarter that ended in Dec. 2020 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2020 ) / Average Total Inventories (Q: Dec. 2020 )
=0.128 / 0.1105
=1.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Remedent Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Remedent's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Remedent (Remedent) Business Description

Traded in Other Exchanges
N/A
Address
Zuiderlaan 1-3, Box 8, Ghent, BEL, 9000
Remedent Inc is a manufacturer of cosmetic dentistry products in Europe. The company is engaged in the research, development, and manufacturing of oral care and cosmetic dentistry products. It designs, develops, manufactures, and distributes cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, the Middle East, and the United States. The product line of the company includes SmileWise, the SmileMe mirror, and the Condor intra-oral 3D scanner.
Executives
Stuart Steinberg 10 percent owner 85 BELLEVUE AVENUE, RYE NY 10580
Marxe Austin W & Greenhouse David M 10 percent owner C/O SPECIAL SITUATIONS FUNDS, 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022
Gruber & Mcbaine Capital Management Llc 10 percent owner 234 VAN NESS, STE 5, SAN FRANCISCO CA 94133
Stephen Farley Ross director, officer: CFO; Secretary XAVIER DE COCKLAAN 42 DEURLE C9 9831
Fred Kolsteeg director XAVIER DE COCKLAAN 42 DEURLE C9 9831
Acker Philippe Van director C/O REMEDENT, INC. XAVIER DE COCKLAAN 42 9831 DEURLE C9 9831
Robin List other: Former Officer and Director XAVIER DE COCKLAAN 42 DEURLE C9 9831
Roger Leddington officer: Sr VP & Head of US Marketing C/O REMEDENT, INC. XAVIER DE COCKLAAN 42 DEURLE C9 9831
Guy Devreese director, officer: Chairman of the Board XAVIER DE COCKLAAN 42 DEURLE C9 9831
Judd Darrin Hoffman officer: VP Worldwide Sales/Operations 702A JUANITA AVENUE REDONDO BEACH CA 90277
Nv Lausha 10 percent owner C/O REMEDENT, INC. XAVIER DE COCKLAAN 42 9831 DEURLE C9 9831

Remedent (Remedent) Headlines

From GuruFocus

Making Money from Smiles

By Frank Lind Frank Lind 05-26-2011